Background-Balloon pulmonary angioplasty (BPA) has become an alternative therapy for patients with chronic thromboembolic pulmonary hypertension who are ineligible for pulmonary endarterectomy. We retrospectively investigated intravascular ultrasound measurements to elucidate how the lumen enlarges immediately after BPA. Methods and Results-A total of 326 lesions in 71 patients with chronic thromboembolic pulmonary hypertension were analyzed. The cross-sectional areas (CSAs) of the external elastic membrane and lumen measured by intravascular ultrasound before and after BPA were assessed for each lesion type (type A, ring-like stenosis lesions; type B, web lesions; type C, subtotal occlusion lesions). Comparing the lesion types, the proportion of the area occupied by fibrous tissue was smallest in the type A lesions and largest in the type C lesions. The mean lesion lumen CSA was increased after BPA because of an increase in external elastic membrane CSA (from 23.2±12.9 to 27.2±14.3 mm 2 ; P<0.001) with a slight decrease in fibrous tissue plus media CSA (from 17.7±11.7 to 17.3±11.1 mm 2 ; P<0.001). The change in lumen CSA correlated strongly with the change in external elastic membrane CSA (r 2 =0.762; P<0.001). Conclusions-Lumen enlargement immediately after BPA was obtained by the overall vessel expansion induced by a stretch of the arterial wall. In addition, the amount of fibrous tissue depended on each lesion type. Thus, it might be beneficial to change the balloon size to correspond with the lesion type. (Circ Cardiovasc Interv. 2018;11:e006010.
C hronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary hypertension caused by chronic stenosis or obstruction of the pulmonary arteries because of fibrous tissue. 1 Increased pulmonary vascular resistance eventually leads to progressive pulmonary hypertension and right heart failure. The prognosis of patients with CTEPH is poor and depends on the severity of pulmonary hypertension before treatment. 2 The only established and potentially curative treatment currently available for CTEPH is the surgical removal of the obstructive material via pulmonary endarterectomy (PEA). 3 However, not all patients are eligible for PEA because of advanced age, comorbidities, and the location of fibrous tissue. 4 In 1988, balloon pulmonary angioplasty (BPA) was first performed for a case of CTEPH that was ineligible for PEA. 5 Feinstein et al 6 reported significant hemodynamic improvements after BPA in 18 cases of CTEPH in 2001. However, it was not widely accepted as a therapeutic option for inoperable patients with CTEPH because of the high risk of complications and its lesser therapeutic efficacy compared with PEA.
In 2012, some Japanese institutions, including ours, refined BPA and reported favorable outcomes. [7] [8] [9] BPA is now performed worldwide and has been described as a therapeutic option in the latest guidelines. 3 It is not fully understood how the lumen enlarges immediately after simple balloon dilatation at each lesion although fibrous tissue cannot be removed from the vessels by BPA, unlike PEA. Intravascular ultrasound (IVUS) has been used to study the mechanism of lumen enlargement with coronary balloon angioplasty. [10] [11] [12] We performed IVUS to measure lumen diameter during BPA. 7 Therefore, in the present study, we retrospectively assessed IVUS images before and immediately after BPA in patients with CTEPH and analyzed the changes in the pulmonary arteries at the target lesions.
Methods
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure. Vessel Stretching After BPA: IVUS Study
Patient and Lesion Selection
Consecutive patients with CTEPH who underwent BPA at National Hospital Organization Okayama Medical Center between January 2012 and January 2013 were enrolled in this study. BPA was performed after institutional review board approval, and written informed consent on the entire BPA procedure, including IVUS, was obtained from each patient before BPA. With regard to the retrospective analysis of IVUS images, the protocol was approved by the National Hospital Organization Okayama Medical Center's Institutional Review Board, and written informed consent from each patient was waived because this was a retrospective study. One author (H.M.) had full access to all the data in the study and takes responsibility for its integrity and the data analysis.
A diagnosis of CTEPH was made as described in our previous reports. 7, 13 All patients were diagnosed as inoperable by experienced surgeons based on lesion accessibility, hemodynamics, age, and comorbidities.
We analyzed lesions where we could obtain adequate IVUS images before and immediately after BPA. We could not perform IVUS in lesions having too severe stenosis and too sharp branch angles to pass through the IVUS catheter. There were other lesions where IVUS after BPA was infeasible because of post-BPA complications. Among the 5 angiographic thromboembolic lesion types we previously reported, 13 we excluded 2 patients with type E: tortuous lesions, because we realized that it was impossible to perform IVUS for this lesion type after several failed attempts ( Figure I in the Data Supplement).
Selective Pulmonary Angiography and BPA Procedure
BPA procedures and perioperative management were based on previous reports. 7, 13 However, there were some modifications in this study. We did not routinely use preoperative epoprostenol and postoperative noninvasive positive ventilation because they were not effective in a previous study. 7 We performed BPA using the biplane angiographic system (Allura Xper FD10/10; Phillips Electronics, Amsterdam, the Netherlands). Briefly, we placed a 9F indwelling sheath in the internal jugular or femoral vein. A 6F long sheath was introduced into the pulmonary main trunk via the 9F sheath using a 0.035-inch wire. Selective pulmonary angiography was performed before BPA to confirm the location and the thromboembolic lesion type. A Mach1 peripheral MP (Boston Scientific, Natick, MA) catheter was generally used as a guiding catheter. The contrast medium was injected from segmental arteries. Selective pulmonary angiography and BPA were conducted using 8-inch images. We used a 0.014-inch wire (Agosal XS 0.8; Asahi Intec, Tokyo, Japan; or Chevalier floppy; Cordis/ Johnson & Johnson, New Brunswick, NJ) to cross the targeted lesion. After the 0.014-inch wire crossed the targeted lesions, we evaluated the characteristics of the lesions and vessel diameter based on angiographic findings. To confirm the diameter measured by pulmonary angiography, we routinely tried to perform the IVUS examination before and immediately after BPA. After determining the vessel diameter, we dilated the vessel using appropriately sized (2.0-8.0 mm) balloon catheters.
IVUS Imaging Systems
We used Eagle Eye Platinum (Volcano, San Diego, CA) for the IVUS examination. Before imaging, time-gain compensation, overgain, contrast, and reject levels were adjusted to predefined settings to maintain uniform ultrasound image quality. IVUS imaging was performed before and immediately after BPA, and the data obtained were recorded for offline quantitative analysis. The imaging catheter was advanced ≈10 mm distal to the lesion; complete uninterrupted imaging runs were performed manually back to 10 mm proximal to the lesion.
Quantitative IVUS Analysis
All ultrasound images were reviewed and evaluated for both qualitative and quantitative parameters. Images were digitized to perform a morphometric analysis with commercially available planimetry software (Volcano s5 Imaging System, Volcano). All IVUS analyses were performed by 3 individuals blinded to the clinical data and angiographic information. When there was any discordance between the 3 observers, a consensus reading was obtained. Figure 1 shows representative IVUS images before and immediately after successful BPA. The definition of morphometric parameters consisted of the vessel and lumen cross-sectional area (CSA) and were based on previous reports on coronary intervention. [14] [15] [16] ChromaFlo (Volcano) was used to clearly visualize and distinguish the lumen area and fibrous tissue area. Lumen CSA was defined as the area detected by ChromaFlo. The external elastic membrane (EEM) CSA represented the area within the border between the hypoechoic media and echo-reflective adventitia. The fibrous tissue plus media (FT+M) CSA was calculated as EEM CSA minus lumen CSA and was used as a measure of the amount of fibrous tissue. We measured CSA at the point where stenosis is the most severe within the lesion in each subsegmental pulmonary artery. The same anatomic lesion site image slices were analyzed before and after the intervention, and the differences were compared using reproducible axial landmarks (eg, bifurcation of subsegmental branches and small proximal or distal side branches).
Clinical Outcomes After BPA
Patients were followed up and underwent right-sided heart catheterization at baseline, 6 months, and 1 year after the final procedure of BPA. The effectiveness of BPA was evaluated by improvement in the World Health Organization (WHO) functional class, plasma levels of brain natriuretic peptide, 6-minute walk distance, and hemodynamic parameters (systolic pulmonary arterial pressure [PAP], diastolic PAP, and mean PAP, cardiac index, and pulmonary vascular resistance).
Statistical Analysis
Results are expressed as the mean±SD. Normal distribution of each data subset was checked by using graphical methods and a Shapiro-Wilk test. To examine the difference of repeated measures, linear mixed effect models were conducted to analyze the time course of systolic PAP and mean PAP between baseline and the 6 months after BPA, baseline and the 1 year after BPA. Generalized
WHAT IS KNOWN
• Balloon pulmonary angioplasty has become a therapeutic option for patients with chronic thromboembolic pulmonary hypertension who are ineligible for pulmonary endarterectomy.
• Previous study demonstrated that thromboembolic lesion types influence the outcome and complication rate of balloon pulmonary angioplasty.
• It is not fully understood how the lumen enlarges immediately after balloon pulmonary angioplasty by simple balloon dilatation.
WHAT THE STUDY ADDS
• According to the analysis of intravascular ultrasound, the amount of fibrous tissue depends on each lesion type.
• Lumen enlargement immediately after balloon pulmonary angioplasty was obtained by the overall vessel expansion induced by a stretch of the arterial wall. Vessel Stretching After BPA: IVUS Study linear mixed effect models were also used to assess the difference of 6-minute walk distance, brain natriuretic peptide, cardiac index, and pulmonary vascular resistance. In both the linear mixed effect models and generalized linear mixed effect models, patients were treated as random effect variables. The Bonferroni correction was applied to correct for multiple testing between the 3 time points. WHO functional class is expressed as the median and number of patients in each class, and changes in WHO functional class were evaluated using the Friedman test. Comparisons of the percentage of the area occupied by fibrous tissue between the 3 lesion types were performed using the Kruskal-Wallis test. Comparisons of absolute change in each CSA before and after BPA were performed using the Wilcoxon signed-rank test for each continuous variable. The correlation between the change in EEM CSA and FT+M CSA and the change in lumen CSA was analyzed using the Spearman rank correlation coefficient. All analyses were performed with IBM SPSS Statistics 20 (IBM, Armonk, NY). Statistical significance was defined as P<0.05.
Results

Patients' Baseline Characteristics
From January 2012 to January 2013, we consecutively performed 220 BPA procedures for 73 patients with CTEPH who were ineligible for PEA ( Figure I in the Data Supplement). Eighteen BPA procedures for 2 patients were excluded because all the lesions in both lungs consisted of type E lesions. Therefore, 202 BPA procedures for 71 patients with CTEPH were enrolled in this study. One patient had residual pulmonary hypertension after PEA. Baseline patient characteristics are shown in Table 1 . The mean age was 63.5 (range: 30-83) years old at the time of the first BPA procedure. The mean duration between diagnosis and study entry was 38.4±40.8 months. Most patients were in the WHO functional class III and had severe hemodynamics with mean PAP exceeding 40 mm Hg. Fifty-four patients (76.1%) were treated with at least 1 specific pulmonary vasodilator and 26 (48.1%) of them received combination therapy.
Outcomes and Complications of BPA
The clinical parameters before BPA and 6 months and 1 year after the final BPA procedure are summarized in Table 1 . WHO functional class, 6-minute walk distance, and plasma brain natriuretic peptide levels were improved after BPA. All the hemodynamic parameters, except for cardiac index, were also improved after BPA. The improvements of these parameters were maintained at follow-up. In the 202 BPA procedures, pulmonary injury after BPA, characterized by hypoxia and newly developed chest radiographic opacities, occurred in 36 procedures (17.8%) and hemosputum occurred in 34 procedures (16.8%). Two BPA procedures in 2 patients required intratracheal intubation and mechanical ventilator support because of severe pulmonary injury after BPA. One of them rapidly improved and could be extubated the next day after BPA. Another patient required percutaneous cardiopulmonary support to maintain oxygenation and died in the hospital because of a deterioration of right heart failure 12 days after the final BPA procedure.
Lesion and Procedural Characteristics
We enrolled 735 lesions during this study period, and 326 of these (44.4%) were analyzed by IVUS before and immediately after BPA ( The characteristics of target lesions and BPA procedures are shown in Table 2 . The BPA-targeted lesions were predominantly distributed in the right lung (70.2%) compared with the left lung (29.8%). Thromboembolic type B lesions were observed more frequently than other lesion types and accounted for ≈80% of all the lesions. The median balloon size was 4.0 mm (range: 2.0-8.0 mm), and average balloonto-artery ratio was 0.73 (range: 0.25-1.36). Figure 2 shows the representative angiographic and IVUS images before and immediately after BPA between the lesion types. In the type A lesion, the IVUS image immediately after BPA showed a larger lumen area because of overall vessel stretching (Figure 2A ). In the type B lesion, the enlargements of the lumen area at the lesion site were because of overall vessel stretching and structural destruction of fibrous tissue with recanalized channels forced to one side of the vessel lumen, and a lumen was newly formed by the BPA (Figure 2B ). In the type C lesion, the amount of fibrous tissue was larger than for other lesion types, and the enlargement of the lumen area was also because of a combination of vessel stretching and minor compression of the fibrous tissue ( Figure 2C ).
Difference of IVUS Images Among Lesion Types
To elucidate the difference in the amount of fibrous tissue on planar images between lesion types, we evaluated the IVUS measurements in 326 lesions based on each lesion type. (Figure 3 ).
IVUS Measurements Before and Immediately After BPA
We evaluated the change of lumen CSA, EEM CSA, and FT+M CSA before and immediately after BPA (Figure 4 Values are expressed mean±SD or n (%) unless otherwise specified. BPA indicates balloon pulmonary angioplasty; and IVUS, intravascular ultrasound. Vessel Stretching After BPA: IVUS Study
Discussion
It is apparent that lumen enlargement in stenotic or obstructed lesions within pulmonary arteries leads to the reduction of pulmonary vascular resistance and improvement of clinical status after BPA for patients with CTEPH. 7 However, how lumens enlarge immediately after BPA by only the dilating balloon has not been studied in detail. To our knowledge, this is the first study to analyze IVUS data of pulmonary arteries after BPA. This study showed that (1) lumen enlargement immediately after BPA is mainly because of overall vessel stretching with minor compression of the fibrous tissue, and (2) the percentage of the lumen area occupied by fibrous tissue depended on each lesion type, and (3) IVUS could never become a standard tool to select balloon size because of its high frequency of inability to perform.
In coronary balloon angioplasty, vessel expansion or stretching produced by tears, cracks, and dissection of the vessel wall is a predominant mechanism of lumen enlargement. 10, 11 This seems reasonable because cracks and dissections of the vessel intima and media allow the entire vessel to be stretched; with the vessel no longer constrained by dense, fibrocalcific plaque after the balloon inflation. In the present study, changes in the lumen CSA of pulmonary arteries strongly correlated with changes in EEM CSA. Thus, lumen enlargement immediately after BPA would be mainly because of vessel stretching. Because we could not evaluate the cracks or dissections of pulmonary arteries in the present analysis, we do not know whether they occurred at the BPA-treated sites. However, we observed by IVUS images that the fibrous tissue was forced to one side of the vessel lumen with the disruption of the meshwork structure ( Figure 2B ). We also previously reported pathological findings in lesions after BPA, where balloon dilatation caused the dissection of the tunica media in treated sites. 17 In another patient, the fibrous tissue with recanalized channels was forced to one side of the vessel lumen, and a lumen was newly formed by BPA without dissection of the vessels. 18 These reports suggest that dissection or cracks in targeted vessels may help enlargement although this was unobserved with IVUS.
The analysis of IVUS images after coronary balloon angioplasty has also revealed that lumen enlargement is because of plaque reduction, such as compression and plaque redistribution, depending on the device and plaque composition. 12, 19 Among them, plaque reduction by compression or expression of soft lipid-rich components from the plaque into the lumen or adjacent segments of the vessel wall is considered to be one of the important mechanisms of lumen enlargement. 12, 19 Because we evaluated the fibrous tissue only at a In contrast to the coronary balloon angioplasty, the main component of lesions within the pulmonary vessels in CTEPH is not the soft plaque or fresh thrombus but fibrous tissue, which consists of a hard component rich in fibrous elements. 20, 21 In the present study, the correlation between the change of lumen CSA and the change of FT+M CSA was weak, and the lumen enlargement after BPA did not notably depend on the compression of fibrous tissue. Our results indicated that the lumen enlargement in BPA differed from that of coronary balloon angioplasty.
The most frequent and characteristic complication of BPA is BPA-related pulmonary injury. 13 One of the causes of this complication would be oozing hemorrhage from vessel injury at the ballooning site. 13 The present study revealed that the percentage of lumen area occupied by fibrous tissue differed depending on lesion type. The larger the amount of fibrous tissue, the greater the vessel stretch needed to obtain the same lumen area; this would lead to the dissection of pulmonary vessels and could cause pulmonary injury. A previous report of a high incidence of BPA-related pulmonary injury in the type C lesion seems to support this hypothesis. 13 To reduce the risk of BPA-related pulmonary injury, the use of a balloon with a diameter smaller than the vessel diameter at the lesion is necessary, especially for type C lesions. The change of these parameters on IVUS before and immediately after BPA were also investigated according to lesion type. Although both the lesion lumen CSA and the lesion EEM CSA in type A lesions increased immediately after BPA, the lesion FT+M CSA did not significantly change. Regarding type B and type C lesions, the lesion lumen CSA and lesion EEM CSA increased with a slight decrease of FT+M CSA. All, all lesions; type A, type A lesions; type B, type B lesions; type C, type C lesions. Gray bars, before BPA; and black bars, after BPA. Although this IVUS study revealed how lumens enlarge immediately after BPA, the success rate of IVUS observation during BPA is lower compared with percutaneous coronary intervention, which is reportedly 97.3%. 22 In 208 of 735 lesions (28.3%), we could not perform IVUS before BPA. This low success rate is a major limitation of IVUS performed during BPA. In addition, it was difficult to identify the same sites before and after BPA because of less reproducible landmarks, such as calcified deposits. The swing motion of the IVUS catheter caused by the heart beat and respiratory movement of the pulmonary vessels also made the IVUS procedure difficult. IVUS-guided BPA for the selection of balloon size would be ideal but unrealistic considering the low success rate of IVUS.
Study Limitations
There are some limitations to this study. First, this study was conducted retrospectively at a single center with a limited number of patients. Second, only 44.4% of the lesions were able to be analyzed by IVUS before and immediately after BPA in this study. This low analytic rate is considered to be a major limitation of this study. Third, as mentioned, type D and type E lesions were excluded in this study, and how lumens enlarge after BPA in these lesion types remains unclear. Fourth, we only evaluated the single planar cut image by IVUS, and we did not evaluate fibrous tissue longitudinally. In addition, we only analyzed IVUS data before and immediately after BPA, not at follow-up. A more detailed investigation of IVUS, including follow-up data, is necessary to elucidate the true mechanism of lumen enlargement after BPA over time.
Conclusions
Lumen enlargement immediately after BPA would be because of an overall vessel expansion induced by the stretching of the arterial wall. In addition, the amount of fibrous tissue depended on each lesion type. Thus, it might be beneficial to change the balloon size to correspond with the lesion type.
